Quest Partners LLC Intellia Therapeutics, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 20,738 shares of NTLA stock, worth $203,025. This represents 0.03% of its overall portfolio holdings.
Number of Shares
20,738
Previous 19,748
5.01%
Holding current value
$203,025
Previous $406 Million
40.42%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding NTLA
# of Institutions
324Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$123 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$94.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$94 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$50.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$48.5 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $744M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...